Insider Shareholders with Direct Ownership of Leap Therapeutics, Inc. (LPTX)
This section provides a comprehensive overview of the insiders with direct ownership of Leap Therapeutics, Inc. (LPTX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
LEAP THERAPEUTICS, INC. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Bei Gene, Ltd.
> 10% Shareholder |
2,543,800 | 0 | 7,348,437 $27.5 Million | 1 |
Sep 24, 2021
Added 25.72%
|
|
Douglas E Onsi
CEO,CFO,Pres.,GC,Treas.,&Sec. |
668,106 | 0 | 73,646 $275,436 | 2 |
Jan 26, 2024
Added 9.24%
|
|
Augustine Lawlor
Chief Operating Officer |
5,000 | 0 | 5,086 $19,021 | 1 |
Jan 26, 2024
Added 49.57%
|
|
Christopher Mirabelli
Director |
5,000 | 0 | 5,086 $19,021 | 1 |
Jan 26, 2024
Added 49.57%
|
|
Cynthia Sirard
Chief Medical Officer |
5,000 | 0 | 5,000 $18,700 | 1 |
Jan 26, 2024
Added 50.0%
|
|
John Mark O'Mahony
Chief Manufacturing Officer |
5,000 | 0 | 5,000 $18,700 | 1 |
Jan 26, 2024
Added 50.0%
|
|
Health Care Ventures Viii, L.P.
> 10% Shareholder |
0 | 2,618,406 | 0 $0 | 1 |
Dec 28, 2020
Reduced 100.0%
|